This list is based on the watchlists of people on Stock Events who follow QNTM. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
Show more...
FAQ
What is Quantum BioPharma stock price today?▼
The current price of QNTM is $3.98 USD — it has decreased by -9.75% in the past 24 hours. Watch Quantum BioPharma stock price performance more closely on the chart.
What is Quantum BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum BioPharma stocks are traded under the ticker QNTM.
Is Quantum BioPharma stock price growing?▼
QNTM stock has fallen by -16.56% compared to the previous week, the month change is a +10.86% rise, over the last year Quantum BioPharma has showed a +12.59% increase.
What is Quantum BioPharma market cap?▼
Today Quantum BioPharma has the market capitalization of 15.19M
When is the next Quantum BioPharma earnings date?▼
Quantum BioPharma is going to release the next earnings report on May 08, 2026.
What were Quantum BioPharma earnings last quarter?▼
QNTM earnings for the last quarter are -1.26 USD per share, whereas the estimation was -2.66 USD resulting in a +52.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quantum BioPharma revenue for the last year?▼
Quantum BioPharma revenue for the last year amounts to 0 USD.
What is Quantum BioPharma net income for the last year?▼
QNTM net income for the last year is -28.41M USD.
In which sector is Quantum BioPharma located?▼
Quantum BioPharma operates in the Health Care sector.
When did Quantum BioPharma complete a stock split?▼
The last stock split for Quantum BioPharma was on October 27, 2025 with a ratio of 2:1.
Where is Quantum BioPharma headquartered?▼
Quantum BioPharma is headquartered in Toronto, CA.